|
RU2127274C1
(ru)
*
|
1992-09-25 |
1999-03-10 |
Эли Лилли Энд Компани |
СПОСОБ ПОЛУЧЕНИЯ 5-ЗАМЕЩЕННЫХ ПИРРОЛО (2,3-α)ПИРИМИДИНОВ
|
|
US7863444B2
(en)
|
1997-03-19 |
2011-01-04 |
Abbott Laboratories |
4-aminopyrrolopyrimidines as kinase inhibitors
|
|
CA2304656A1
(en)
*
|
1997-09-26 |
1999-04-08 |
Eli Lilly And Company |
Processes and intermediates useful to make antifolates
|
|
ZA987550B
(en)
*
|
1997-09-26 |
2000-02-21 |
Lilly Co Eli |
Processes and intermediates useful to make antifolates.
|
|
US6713474B2
(en)
|
1998-09-18 |
2004-03-30 |
Abbott Gmbh & Co. Kg |
Pyrrolopyrimidines as therapeutic agents
|
|
US7071199B1
(en)
|
1999-09-17 |
2006-07-04 |
Abbott Gmbh & Cco. Kg |
Kinase inhibitors as therapeutic agents
|
|
IL150480A0
(en)
*
|
2000-02-25 |
2002-12-01 |
Lilly Co Eli |
A NOVEL-CRYSTALLINE FORM OF N-[4-[2-(2-AMINO-4, 7-DIHYDRO-4-OXO-3H-PYRROLO[2, 3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR
|
|
JP2008543973A
(ja)
|
2006-08-14 |
2008-12-04 |
シコール インコーポレイティド |
ペメトレキセドの中間体の調製方法
|
|
EP1934226A2
(en)
|
2006-08-14 |
2008-06-25 |
Sicor, Inc. |
Highly pure pemetrexed diacid and processes for the preparation thereof
|
|
WO2008021411A2
(en)
*
|
2006-08-14 |
2008-02-21 |
Sicor Inc. |
Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid
|
|
EP2270012A1
(en)
*
|
2006-08-14 |
2011-01-05 |
Sicor, Inc. |
Crystalline form of pemetrexed diacid and process for the preparation thereof
|
|
CN101687872A
(zh)
*
|
2007-04-03 |
2010-03-31 |
雷迪博士实验室有限公司 |
培美曲塞的固体形式
|
|
US8232376B2
(en)
|
2007-06-29 |
2012-07-31 |
Ricoh Company, Ltd. |
Azo compound and method of preparing the azo compound
|
|
US20090069349A1
(en)
*
|
2007-09-12 |
2009-03-12 |
Protia, Llc |
Deuterium-enriched pemetrexed
|
|
CN101684121B
(zh)
*
|
2008-09-22 |
2013-04-03 |
重庆医药工业研究院有限责任公司 |
培美曲塞二酸的新晶型及其制备方法
|
|
TW201118098A
(en)
*
|
2009-08-13 |
2011-06-01 |
Reddy S Lab Liimited Dr |
Processes for preparing pemetrexed
|
|
US20130183268A1
(en)
|
2010-07-19 |
2013-07-18 |
Bayer Healthcare Llc |
Drug combinations with fluoro-substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
|
IT1401677B1
(it)
|
2010-07-22 |
2013-08-02 |
Chemi Spa |
Nuovo processo per la sintesi di pemetrexed sale disodico
|
|
CN102372719B
(zh)
*
|
2010-08-26 |
2013-10-30 |
齐鲁制药有限公司 |
培美曲塞二甲酯对甲苯磺酸盐晶型及其制备方法
|
|
WO2012056285A1
(en)
|
2010-10-25 |
2012-05-03 |
Fresenius Kabi Oncology Ltd. |
An improved process for the preparation of pemetrexed
|
|
KR101308767B1
(ko)
|
2011-01-20 |
2013-12-31 |
에스티팜 주식회사 |
고 순도 페메트렉세드 디에틸 에스테르의 제조방법 및 이 방법을 포함하는 페메트렉세드 이나트륨염의 제조방법
|
|
ITRM20120398A1
(it)
|
2012-08-08 |
2014-02-09 |
Berlin Chemie Ag |
Procedimento di sintesi pemetrexed e suo sale di lisina.
|
|
CN102887902B
(zh)
*
|
2012-10-10 |
2015-05-20 |
北京莱瑞森医药科技有限公司 |
一种合成高纯度培美酸的制备工艺
|
|
CN103086912A
(zh)
*
|
2012-11-14 |
2013-05-08 |
湖北一半天制药有限公司 |
用于制备培美曲塞及其中间体的方法
|
|
EP2983649A1
(en)
|
2013-04-12 |
2016-02-17 |
Actavis Group PCT ehf |
Pemetrexed formulation
|
|
ES2657944T3
(es)
|
2013-06-14 |
2018-03-07 |
Synthon B.V. |
Sal estable de arginina de pemetrexed y composiciones que la comprenden
|
|
CN107628947B
(zh)
*
|
2017-09-14 |
2020-07-28 |
浙江工业大学 |
一种培美曲塞二钠关键中间体的制备方法
|
|
JP7491572B2
(ja)
|
2018-02-07 |
2024-05-28 |
エル．イー．エー．エフ． ホールディングス グループ エルエルシー |
アルファポリグルタミン酸化ペメトレキセドおよびその使用
|
|
CA3090483A1
(en)
|
2018-02-07 |
2019-08-15 |
L.E.A.F. Holdings Group Llc |
Gamma polyglutamated pemetrexed and uses thereof
|
|
US12280053B2
(en)
|
2019-05-01 |
2025-04-22 |
Intas Pharmaceuticals Ltd. |
Stable, ready to use aqueous pharmaceutical composition of pemetrexed
|